new biotech drug for diabetic foot ulcers
February 1999
You'll see a new biotech drug for diabetic foot ulcers...called Regranex (becaplermin gel).
It contains a platelet-derived growth factor to stimulate the growth of new tissue...resulting in a modest increase in healing.
This is important. Diabetic foot ulcers are extremely hard to treat...and can lead to serious infections and amputation.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive